A novel model improves risk prediction for hypertrophic cardiomyopathy (HCM), according to results of a study.
UBC Okanagan researchers, working with scientists at BC Cancer–Kelowna, have developed a groundbreaking AI model that can ...
The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during ...